The software was found to improve CHD detection by more than 15% and provide conclusions in 98.8% of exams.
BrightHeart’s AI demonstrates promise in congenital heart defect detection
Previous
Previous
BrightHeart Obtains Second FDA Clearance for Expansion of Platform Capabilities - Adding Tablet Support For Fetal Heart Ultrasound Evaluations
Next
Next